Doctrin Raises €13 Million to Accelerate International Expansion
Swedish health tech company Doctrin raises €13 million to fuel further expansion. The round is led by existing investors HealthCap, Swedbank Robur and Capio. Norron Asset Management, with a special focus on investments for a sustainable society, is added as one of the major new investors. The company is currently active in Sweden, the Czech Republic, Norway and the UK. This investment means that the company will accelerate its expansion into new markets and continue development into new medical specialities.
Doctrin is one of Sweden’s leading suppliers of digital solutions for “digi-physical” healthcare with customers in primary, specialist and dental care as well as in insurance. Among the customers are several of Sweden’s most well-known and highly specialized care providers, including the Ersta Hospital, the Karolinska Hospital and Sophiahemmet. The company is the leading supplier to private primary care providers with Capio, Praktikertjänst, Achima Care and Familjeläkarna among the customers, which together make up more than 50 percent of the Swedish private primary care market.
Doctrin offers a unique medical content for medical history taking which is automatically turned into a medical report of such quality that healthcare staff can make medical decisions based on it, in a very short time. Earlier this year, Doctrin Network was launched, a new feature that enables advanced collaboration between healthcare units. This enables a seamless patient journey where patients are guided within and have access to the healthcare provider’s entire eco-system, without geographical limitations. A significant step towards Doctrin’s vision of patient centric healthcare, free from barriers.
During the pandemic year of 2020, the number of consultations increased by as much as 280 percent, and today more than 2,000,000 patient contacts have been made on the platform.
“In the past year, we have seen an enormous interest in our solutions. 2020 is the year we had a real breakthrough in specialist care, e.g. pediatric and adolescent medicine and orthopedics. Unlike many digital platforms, which primarily offer solutions for remote consultations, we focus on solving healthcare’s long-term challenge, the lack of resources. We look forward to taking the next development step expanding into new markets and medical areas”, says Anna-Karin Edstedt Bonamy, CEO Doctrin.
In 2020, Doctrin continued its international expansion by launching in the UK alongside the Czech Republic and Norway. The company also expanded its operations in Norway by winning the Norwegian Health Directorate’s procurement of triage systems.
People In This Post
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more